The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ErratumFull Access

Erratum

The article “DSM-5 Field Trials Test Proposals for Changes to Diagnostic Criteria” in the September 17 issue contained incorrect information about the number of DSM-5 field trials taking place. It was stated that 22 field trials will take place in individual practices and routine clinical settings.

These field trials collectively represent one specific type of field trial (the other being field trials that are to take place in large, academic-medical settings). As stated correctly in the article, these routine clinical settings will yield at least double the number of patients recruited from the large, academic-medical settings. However, there will not be 22 routine clinical practice field trials; there will be one field trial taking place in 11 large sites, and one field trial taking place among approximately 3,500 clinicians in the routine clinical practice sites—with each clinician interviewing two randomly selected patients.